Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Net Cash Flow (2016 - 2025)

Icu Medical (ICUI) has disclosed Net Cash Flow for 17 consecutive years, with $7.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 41.58% year-over-year to $7.7 million, compared with a TTM value of -$9.4 million through Dec 2025, down 115.94%, and an annual FY2025 reading of -$9.4 million, down 115.94% over the prior year.
  • Net Cash Flow was $7.7 million for Q4 2025 at Icu Medical, up from $993000.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $58.9 million in Q3 2021 and bottomed at -$220.2 million in Q1 2022.
  • Average Net Cash Flow over 5 years is -$4.1 million, with a median of $4.0 million recorded in 2023.
  • The sharpest move saw Net Cash Flow surged 299.69% in 2024, then tumbled 2112.92% in 2025.
  • Year by year, Net Cash Flow stood at $34.4 million in 2021, then crashed by 204.92% to -$36.1 million in 2022, then surged by 246.2% to $52.8 million in 2023, then tumbled by 89.66% to $5.5 million in 2024, then soared by 41.58% to $7.7 million in 2025.
  • Business Quant data shows Net Cash Flow for ICUI at $7.7 million in Q4 2025, $993000.0 in Q3 2025, and $3.7 million in Q2 2025.